 Kenneth Tyler
Concepts (771)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reoviridae Infections | 40 | 2019 | 55 | 8.630 |
Why?
| | West Nile Fever | 22 | 2023 | 51 | 7.730 |
Why?
| | Encephalitis, Viral | 23 | 2021 | 44 | 6.380 |
Why?
| | West Nile virus | 17 | 2023 | 38 | 6.320 |
Why?
| | Enterovirus D, Human | 13 | 2023 | 76 | 5.930 |
Why?
| | Enterovirus Infections | 13 | 2023 | 164 | 5.170 |
Why?
| | Central Nervous System Viral Diseases | 17 | 2023 | 63 | 5.090 |
Why?
| | Reoviridae | 26 | 2019 | 38 | 4.720 |
Why?
| | Myelitis | 20 | 2022 | 88 | 4.710 |
Why?
| | Leukoencephalopathy, Progressive Multifocal | 15 | 2019 | 39 | 4.480 |
Why?
| | Mammalian orthoreovirus 3 | 30 | 2019 | 35 | 4.080 |
Why?
| | Nervous System Diseases | 15 | 2020 | 261 | 3.830 |
Why?
| | Apoptosis | 44 | 2021 | 2484 | 3.730 |
Why?
| | Brain | 37 | 2023 | 2490 | 3.520 |
Why?
| | Antiviral Agents | 19 | 2023 | 654 | 3.160 |
Why?
| | Neuromuscular Diseases | 9 | 2022 | 90 | 2.400 |
Why?
| | Central Nervous System Infections | 7 | 2022 | 39 | 2.350 |
Why?
| | Neurology | 12 | 2017 | 94 | 2.300 |
Why?
| | Zika Virus Infection | 5 | 2017 | 85 | 2.260 |
Why?
| | Encephalitis | 8 | 2022 | 129 | 1.960 |
Why?
| | Acyclovir | 9 | 2020 | 105 | 1.930 |
Why?
| | Neurons | 21 | 2022 | 1345 | 1.910 |
Why?
| | Paralysis | 9 | 2023 | 67 | 1.900 |
Why?
| | Encephalitis, Herpes Simplex | 8 | 2020 | 23 | 1.840 |
Why?
| | Host-Pathogen Interactions | 5 | 2021 | 300 | 1.780 |
Why?
| | Mice | 74 | 2023 | 15520 | 1.740 |
Why?
| | Microglia | 7 | 2023 | 221 | 1.680 |
Why?
| | Animals | 107 | 2023 | 33381 | 1.680 |
Why?
| | Multiple Sclerosis | 5 | 2022 | 384 | 1.530 |
Why?
| | Simplexvirus | 13 | 2020 | 86 | 1.520 |
Why?
| | Meningoencephalitis | 6 | 2021 | 24 | 1.520 |
Why?
| | Herpes Simplex | 7 | 2021 | 90 | 1.400 |
Why?
| | Zika Virus | 4 | 2017 | 61 | 1.400 |
Why?
| | Polymerase Chain Reaction | 17 | 2018 | 1012 | 1.380 |
Why?
| | Communicable Diseases, Emerging | 4 | 2016 | 28 | 1.340 |
Why?
| | Spinal Cord | 8 | 2021 | 367 | 1.320 |
Why?
| | Central Nervous System Diseases | 5 | 2023 | 64 | 1.310 |
Why?
| | Cell Death | 4 | 2022 | 339 | 1.280 |
Why?
| | Humans | 157 | 2023 | 118974 | 1.250 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2022 | 453 | 1.230 |
Why?
| | Herpesviridae Infections | 6 | 2013 | 142 | 1.230 |
Why?
| | Viral Load | 6 | 2023 | 419 | 1.200 |
Why?
| | Meningitis, Viral | 8 | 2020 | 22 | 1.180 |
Why?
| | Virus Replication | 19 | 2021 | 405 | 1.110 |
Why?
| | Central Nervous System | 9 | 2017 | 245 | 1.110 |
Why?
| | Interferon-beta | 4 | 2019 | 82 | 1.100 |
Why?
| | JC Virus | 8 | 2015 | 23 | 1.080 |
Why?
| | Disease Outbreaks | 6 | 2022 | 322 | 1.080 |
Why?
| | Meningitis | 4 | 2023 | 74 | 1.060 |
Why?
| | Disease Models, Animal | 13 | 2023 | 3730 | 1.050 |
Why?
| | Arbovirus Infections | 3 | 2019 | 18 | 1.040 |
Why?
| | Epstein-Barr Virus Infections | 2 | 2022 | 73 | 1.030 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 348 | 1.020 |
Why?
| | Coronavirus Infections | 2 | 2020 | 339 | 1.020 |
Why?
| | Monkeypox virus | 3 | 2023 | 12 | 0.990 |
Why?
| | Motor Neurons | 3 | 2019 | 213 | 0.990 |
Why?
| | Herpesvirus 1, Human | 3 | 2021 | 81 | 0.970 |
Why?
| | Cytokines | 9 | 2022 | 1900 | 0.960 |
Why?
| | Creutzfeldt-Jakob Syndrome | 5 | 2007 | 15 | 0.950 |
Why?
| | Orthoreovirus, Mammalian | 4 | 2011 | 5 | 0.950 |
Why?
| | Signal Transduction | 17 | 2019 | 4709 | 0.940 |
Why?
| | Virion | 3 | 2022 | 78 | 0.940 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2023 | 143 | 0.920 |
Why?
| | Caspase 3 | 7 | 2023 | 243 | 0.920 |
Why?
| | Guillain-Barre Syndrome | 3 | 2020 | 21 | 0.910 |
Why?
| | Dog Diseases | 2 | 2021 | 44 | 0.910 |
Why?
| | Sexual and Gender Minorities | 2 | 2022 | 137 | 0.900 |
Why?
| | Capsid Proteins | 8 | 2004 | 70 | 0.890 |
Why?
| | Natalizumab | 4 | 2019 | 46 | 0.880 |
Why?
| | Minocycline | 2 | 2017 | 28 | 0.880 |
Why?
| | Astrocytes | 5 | 2019 | 177 | 0.850 |
Why?
| | Virus Diseases | 7 | 2009 | 198 | 0.840 |
Why?
| | Spine | 2 | 2017 | 144 | 0.830 |
Why?
| | Fluoxetine | 3 | 2018 | 47 | 0.830 |
Why?
| | Immunity, Innate | 5 | 2021 | 745 | 0.810 |
Why?
| | Meningitis, Bacterial | 4 | 2010 | 51 | 0.810 |
Why?
| | Caspase Inhibitors | 5 | 2011 | 82 | 0.780 |
Why?
| | Exosomes | 1 | 2022 | 92 | 0.770 |
Why?
| | Critical Care | 2 | 2017 | 492 | 0.750 |
Why?
| | Betacoronavirus | 2 | 2020 | 254 | 0.740 |
Why?
| | Encephalitis, Tick-Borne | 2 | 2019 | 8 | 0.740 |
Why?
| | Encephalitis, California | 2 | 2019 | 12 | 0.730 |
Why?
| | Hashimoto Disease | 1 | 2019 | 9 | 0.720 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2019 | 9 | 0.710 |
Why?
| | Axonal Transport | 1 | 2019 | 21 | 0.710 |
Why?
| | Immunosuppressive Agents | 3 | 2015 | 681 | 0.710 |
Why?
| | Zoonoses | 2 | 2009 | 20 | 0.710 |
Why?
| | Cell Line | 18 | 2022 | 2707 | 0.700 |
Why?
| | Periodicals as Topic | 1 | 2021 | 191 | 0.690 |
Why?
| | Immune System | 2 | 2020 | 181 | 0.680 |
Why?
| | Encephalitis, Japanese | 1 | 2018 | 2 | 0.670 |
Why?
| | Orthoreovirus | 5 | 1998 | 6 | 0.670 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 5 | 2009 | 155 | 0.650 |
Why?
| | Prion Diseases | 3 | 2008 | 11 | 0.610 |
Why?
| | Neurosyphilis | 2 | 2013 | 3 | 0.600 |
Why?
| | Hepatitis E | 1 | 2017 | 2 | 0.600 |
Why?
| | Hepatitis E virus | 1 | 2017 | 2 | 0.600 |
Why?
| | Plasma Exchange | 1 | 2017 | 21 | 0.600 |
Why?
| | Herpes Zoster | 2 | 2015 | 336 | 0.600 |
Why?
| | NF-kappa B | 7 | 2010 | 670 | 0.580 |
Why?
| | Virology | 1 | 2016 | 20 | 0.580 |
Why?
| | Antibodies, Monoclonal | 11 | 2009 | 1284 | 0.580 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 15 | 0.580 |
Why?
| | Herpesvirus 3, Human | 3 | 2015 | 389 | 0.580 |
Why?
| | Enzyme Inhibitors | 3 | 2011 | 827 | 0.580 |
Why?
| | Macrophage Activation | 1 | 2017 | 168 | 0.570 |
Why?
| | Myocarditis | 5 | 2009 | 95 | 0.570 |
Why?
| | Viruses | 6 | 2009 | 96 | 0.570 |
Why?
| | Prions | 3 | 2008 | 36 | 0.560 |
Why?
| | Caspases | 9 | 2013 | 269 | 0.540 |
Why?
| | Alzheimer Disease | 1 | 2021 | 513 | 0.540 |
Why?
| | Immunocompromised Host | 5 | 2009 | 200 | 0.530 |
Why?
| | History, 20th Century | 10 | 2016 | 281 | 0.530 |
Why?
| | Thrombocytopenia | 1 | 2017 | 185 | 0.520 |
Why?
| | Toll-Like Receptor 3 | 2 | 2014 | 31 | 0.520 |
Why?
| | Chikungunya Fever | 1 | 2016 | 63 | 0.520 |
Why?
| | Cerebrospinal Fluid | 7 | 2005 | 93 | 0.510 |
Why?
| | Propylene Glycols | 1 | 2015 | 27 | 0.510 |
Why?
| | Glial Fibrillary Acidic Protein | 5 | 2021 | 87 | 0.510 |
Why?
| | Valine | 1 | 2015 | 77 | 0.510 |
Why?
| | Medication Reconciliation | 1 | 2015 | 25 | 0.510 |
Why?
| | Gene Expression Regulation | 6 | 2010 | 2445 | 0.510 |
Why?
| | Sphingosine | 1 | 2015 | 35 | 0.510 |
Why?
| | Anti-Inflammatory Agents | 3 | 2017 | 465 | 0.510 |
Why?
| | Antibodies, Viral | 7 | 2019 | 542 | 0.510 |
Why?
| | Calpain | 4 | 2008 | 54 | 0.500 |
Why?
| | Encephalitis Viruses, Japanese | 1 | 2014 | 1 | 0.490 |
Why?
| | Leukoencephalitis, Acute Hemorrhagic | 2 | 2020 | 3 | 0.490 |
Why?
| | Nervous System | 2 | 2007 | 66 | 0.490 |
Why?
| | Encephalitis, St. Louis | 1 | 2014 | 2 | 0.490 |
Why?
| | Encephalitis Virus, St. Louis | 1 | 2014 | 3 | 0.490 |
Why?
| | Drug Discovery | 1 | 2015 | 124 | 0.490 |
Why?
| | PrPSc Proteins | 2 | 2004 | 5 | 0.480 |
Why?
| | Capsid | 5 | 1997 | 77 | 0.480 |
Why?
| | Receptors, Death Domain | 1 | 2013 | 4 | 0.480 |
Why?
| | Interferon Type I | 2 | 2013 | 129 | 0.480 |
Why?
| | Peripheral Nervous System | 1 | 2013 | 19 | 0.480 |
Why?
| | Viral Proteins | 8 | 2000 | 296 | 0.480 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 5 | 2007 | 56 | 0.460 |
Why?
| | Penicillins | 1 | 2013 | 50 | 0.460 |
Why?
| | Male | 48 | 2023 | 57801 | 0.460 |
Why?
| | Heart | 3 | 2011 | 631 | 0.460 |
Why?
| | Neuroglia | 3 | 2012 | 157 | 0.460 |
Why?
| | Epidemics | 1 | 2014 | 70 | 0.450 |
Why?
| | Viral Nonstructural Proteins | 2 | 2005 | 59 | 0.440 |
Why?
| | Carrier Proteins | 6 | 2013 | 726 | 0.440 |
Why?
| | Phagocytosis | 1 | 2014 | 364 | 0.430 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 455 | 0.430 |
Why?
| | Receptor, Interferon alpha-beta | 2 | 2012 | 22 | 0.430 |
Why?
| | Acute Disease | 6 | 2018 | 940 | 0.430 |
Why?
| | Enterovirus | 3 | 2023 | 72 | 0.430 |
Why?
| | DNA, Viral | 8 | 2003 | 356 | 0.420 |
Why?
| | STAT1 Transcription Factor | 3 | 2012 | 69 | 0.420 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 2 | 2011 | 82 | 0.410 |
Why?
| | Animals, Newborn | 9 | 2021 | 806 | 0.410 |
Why?
| | United States | 13 | 2023 | 12555 | 0.400 |
Why?
| | Brain Diseases | 3 | 2020 | 140 | 0.400 |
Why?
| | bcl-2-Associated X Protein | 1 | 2011 | 46 | 0.390 |
Why?
| | Caspase 8 | 5 | 2013 | 47 | 0.390 |
Why?
| | Gene Expression Profiling | 3 | 2014 | 1597 | 0.380 |
Why?
| | Immunoglobulins, Intravenous | 3 | 2019 | 128 | 0.380 |
Why?
| | fas Receptor | 2 | 2009 | 98 | 0.380 |
Why?
| | Female | 41 | 2021 | 61565 | 0.380 |
Why?
| | History, 19th Century | 10 | 2010 | 61 | 0.380 |
Why?
| | Chemokines | 2 | 2022 | 230 | 0.380 |
Why?
| | Genes, Viral | 9 | 1998 | 93 | 0.380 |
Why?
| | Cysteine Proteinase Inhibitors | 3 | 2001 | 50 | 0.380 |
Why?
| | Virus Internalization | 2 | 2022 | 41 | 0.380 |
Why?
| | Macrophages | 1 | 2017 | 1324 | 0.380 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2007 | 21 | 0.360 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 111 | 0.360 |
Why?
| | Flavivirus Infections | 2 | 2019 | 9 | 0.360 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 228 | 0.360 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2003 | 1171 | 0.360 |
Why?
| | Immunomodulation | 1 | 2010 | 89 | 0.360 |
Why?
| | Up-Regulation | 5 | 2016 | 872 | 0.360 |
Why?
| | Cerebellum | 3 | 2012 | 203 | 0.350 |
Why?
| | Membrane Glycoproteins | 5 | 2004 | 446 | 0.350 |
Why?
| | Enzyme Activation | 3 | 2010 | 828 | 0.350 |
Why?
| | Cell Cycle | 2 | 2002 | 550 | 0.330 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 2 | 2009 | 68 | 0.330 |
Why?
| | Cells, Cultured | 12 | 2013 | 4077 | 0.330 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2009 | 137 | 0.320 |
Why?
| | HeLa Cells | 7 | 2018 | 583 | 0.320 |
Why?
| | Discitis | 1 | 2008 | 3 | 0.320 |
Why?
| | Motor Neuron Disease | 1 | 2008 | 16 | 0.320 |
Why?
| | Bell Palsy | 1 | 2007 | 5 | 0.320 |
Why?
| | Bone Diseases, Infectious | 1 | 2008 | 8 | 0.320 |
Why?
| | Spinal Cord Diseases | 1 | 2008 | 39 | 0.320 |
Why?
| | Caspase 9 | 4 | 2013 | 50 | 0.310 |
Why?
| | Back Pain | 1 | 2008 | 44 | 0.310 |
Why?
| | Janus Kinases | 1 | 2007 | 14 | 0.310 |
Why?
| | Prednisolone | 1 | 2007 | 76 | 0.310 |
Why?
| | Rituximab | 3 | 2021 | 155 | 0.300 |
Why?
| | Cytomegalovirus | 2 | 2004 | 144 | 0.300 |
Why?
| | Wasting Disease, Chronic | 1 | 2007 | 19 | 0.300 |
Why?
| | Kuru | 2 | 2004 | 2 | 0.300 |
Why?
| | Apoptosis Regulatory Proteins | 7 | 2005 | 190 | 0.300 |
Why?
| | Adult | 26 | 2022 | 31512 | 0.290 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 59 | 0.280 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 254 | 0.280 |
Why?
| | Transforming Growth Factor beta | 1 | 2009 | 462 | 0.280 |
Why?
| | Homosexuality, Male | 3 | 2022 | 166 | 0.280 |
Why?
| | Mitochondrial Proteins | 2 | 2005 | 226 | 0.280 |
Why?
| | Feces | 1 | 2008 | 396 | 0.270 |
Why?
| | Integrin alpha4 | 1 | 2005 | 7 | 0.270 |
Why?
| | Cytochromes c | 2 | 2005 | 64 | 0.270 |
Why?
| | Dogs | 4 | 2021 | 371 | 0.270 |
Why?
| | Viral Tropism | 2 | 2018 | 24 | 0.270 |
Why?
| | Mice, Knockout | 7 | 2012 | 2680 | 0.260 |
Why?
| | Child, Preschool | 9 | 2022 | 9491 | 0.260 |
Why?
| | Encephalomyelitis, Eastern Equine | 2 | 2019 | 6 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 10 | 2023 | 3174 | 0.260 |
Why?
| | Herpesvirus 4, Human | 2 | 2022 | 126 | 0.260 |
Why?
| | Opportunistic Infections | 1 | 2005 | 42 | 0.260 |
Why?
| | Health Surveys | 1 | 2007 | 454 | 0.260 |
Why?
| | RNA, Viral | 5 | 2004 | 572 | 0.260 |
Why?
| | Child | 15 | 2022 | 19129 | 0.260 |
Why?
| | Scrapie | 1 | 2004 | 2 | 0.250 |
Why?
| | Nitric Oxide Synthase | 1 | 2005 | 225 | 0.250 |
Why?
| | Intracellular Signaling Peptides and Proteins | 4 | 2013 | 404 | 0.250 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 2003 | 224 | 0.250 |
Why?
| | History, 21st Century | 3 | 2016 | 170 | 0.250 |
Why?
| | Immunologic Factors | 2 | 2021 | 225 | 0.250 |
Why?
| | Oligodendroglia | 2 | 2003 | 152 | 0.240 |
Why?
| | Recombinant Proteins | 3 | 2023 | 1308 | 0.240 |
Why?
| | Cell Nucleus | 2 | 2004 | 580 | 0.240 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2004 | 113 | 0.240 |
Why?
| | Adjuvants, Immunologic | 1 | 2005 | 207 | 0.240 |
Why?
| | Mitochondria | 5 | 2016 | 786 | 0.240 |
Why?
| | Blotting, Western | 5 | 2010 | 1194 | 0.240 |
Why?
| | Hand, Foot and Mouth Disease | 1 | 2023 | 3 | 0.230 |
Why?
| | Medical Tourism | 1 | 2023 | 10 | 0.230 |
Why?
| | Encephalomyelitis, Acute Disseminated | 2 | 2020 | 12 | 0.230 |
Why?
| | Roseolovirus Infections | 1 | 2003 | 6 | 0.230 |
Why?
| | Arthropod Vectors | 2 | 2016 | 7 | 0.230 |
Why?
| | Middle Aged | 23 | 2019 | 27617 | 0.230 |
Why?
| | Age of Onset | 1 | 2005 | 467 | 0.230 |
Why?
| | Neutralization Tests | 4 | 2017 | 66 | 0.230 |
Why?
| | Reassortant Viruses | 3 | 2005 | 7 | 0.230 |
Why?
| | Herpesvirus 6, Human | 1 | 2003 | 13 | 0.230 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2017 | 165 | 0.230 |
Why?
| | Treatment Outcome | 8 | 2019 | 9342 | 0.230 |
Why?
| | Antigens, Viral | 4 | 2009 | 181 | 0.230 |
Why?
| | Immunization, Passive | 3 | 1993 | 81 | 0.230 |
Why?
| | Glucocorticoids | 1 | 2007 | 545 | 0.230 |
Why?
| | Flavivirus | 2 | 2019 | 16 | 0.230 |
Why?
| | Immunohistochemistry | 3 | 2017 | 1691 | 0.220 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 3 | 2009 | 10 | 0.220 |
Why?
| | Encephalomyelitis | 1 | 2022 | 9 | 0.220 |
Why?
| | Disease Progression | 7 | 2010 | 2490 | 0.220 |
Why?
| | Olfactory Mucosa | 1 | 2003 | 59 | 0.220 |
Why?
| | Arthritis, Rheumatoid | 1 | 2011 | 989 | 0.220 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2003 | 80 | 0.220 |
Why?
| | Poliomyelitis | 1 | 2022 | 30 | 0.220 |
Why?
| | Antibodies, Monoclonal, Humanized | 4 | 2017 | 667 | 0.220 |
Why?
| | Organ Culture Techniques | 2 | 2014 | 149 | 0.220 |
Why?
| | HIV Infections | 2 | 2013 | 2459 | 0.220 |
Why?
| | Cytomegalovirus Infections | 1 | 2004 | 187 | 0.210 |
Why?
| | Virulence | 6 | 2005 | 240 | 0.210 |
Why?
| | Densitometry | 1 | 2022 | 30 | 0.210 |
Why?
| | Survival Analysis | 3 | 2018 | 1267 | 0.210 |
Why?
| | Poliovirus | 1 | 2022 | 78 | 0.210 |
Why?
| | Anti-Bacterial Agents | 5 | 2022 | 1510 | 0.210 |
Why?
| | Sequence Analysis, DNA | 4 | 2017 | 755 | 0.210 |
Why?
| | Exanthema | 1 | 2022 | 77 | 0.210 |
Why?
| | Organ Transplantation | 1 | 2004 | 165 | 0.210 |
Why?
| | Pandemics | 2 | 2020 | 1355 | 0.210 |
Why?
| | Ovarian Neoplasms | 1 | 2007 | 420 | 0.210 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 97 | 0.200 |
Why?
| | DNA Repair | 1 | 2003 | 198 | 0.200 |
Why?
| | Nervous System Malformations | 1 | 2022 | 33 | 0.200 |
Why?
| | Peptides | 1 | 2007 | 879 | 0.200 |
Why?
| | CDC2 Protein Kinase | 1 | 2001 | 27 | 0.200 |
Why?
| | Enterovirus A, Human | 1 | 2021 | 12 | 0.200 |
Why?
| | Interferons | 2 | 2014 | 151 | 0.200 |
Why?
| | Stroke | 2 | 2020 | 1047 | 0.200 |
Why?
| | Dipeptides | 1 | 2001 | 51 | 0.190 |
Why?
| | G2 Phase | 1 | 2000 | 33 | 0.190 |
Why?
| | Manuscripts, Medical as Topic | 1 | 2000 | 4 | 0.190 |
Why?
| | Herpes Zoster Ophthalmicus | 1 | 2020 | 5 | 0.190 |
Why?
| | DNA-Directed DNA Polymerase | 2 | 1998 | 45 | 0.190 |
Why?
| | Pigmentation Disorders | 1 | 2020 | 7 | 0.190 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 30 | 0.190 |
Why?
| | Encephalitis Virus, California | 2 | 2019 | 6 | 0.190 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2020 | 22 | 0.190 |
Why?
| | Anti-Infective Agents | 2 | 2022 | 227 | 0.190 |
Why?
| | Ophthalmoplegia | 1 | 1999 | 9 | 0.180 |
Why?
| | Facial Paralysis | 1 | 1999 | 17 | 0.180 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 147 | 0.180 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 1999 | 5 | 0.180 |
Why?
| | Thrombophilia | 1 | 2020 | 68 | 0.180 |
Why?
| | Inflammation | 3 | 2020 | 2566 | 0.180 |
Why?
| | Craniofacial Abnormalities | 1 | 2020 | 58 | 0.180 |
Why?
| | Bunyaviridae Infections | 1 | 2019 | 6 | 0.180 |
Why?
| | Immunoglobulin G | 3 | 2019 | 788 | 0.180 |
Why?
| | Intracranial Hemorrhages | 1 | 2020 | 77 | 0.180 |
Why?
| | Pons | 1 | 1999 | 31 | 0.180 |
Why?
| | Nerve Degeneration | 2 | 2011 | 44 | 0.180 |
Why?
| | Genes, pol | 2 | 1998 | 7 | 0.180 |
Why?
| | Olfaction Disorders | 1 | 2020 | 47 | 0.180 |
Why?
| | Molecular Sequence Data | 4 | 2011 | 2871 | 0.180 |
Why?
| | Mitosis | 1 | 2000 | 172 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2012 | 394 | 0.180 |
Why?
| | Myelitis, Transverse | 1 | 2019 | 3 | 0.170 |
Why?
| | Time Factors | 9 | 2008 | 6412 | 0.170 |
Why?
| | Gliosis | 1 | 2019 | 35 | 0.170 |
Why?
| | North America | 2 | 2019 | 266 | 0.170 |
Why?
| | MAP Kinase Kinase Kinase 1 | 3 | 2004 | 14 | 0.170 |
Why?
| | Writing | 1 | 2000 | 88 | 0.170 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 1 | 2019 | 44 | 0.170 |
Why?
| | rho-Associated Kinases | 1 | 2019 | 84 | 0.170 |
Why?
| | Encephalitis Virus, Japanese | 1 | 2018 | 1 | 0.170 |
Why?
| | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 13 | 0.170 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 108 | 0.170 |
Why?
| | Mental Disorders | 1 | 2007 | 939 | 0.170 |
Why?
| | Abnormalities, Multiple | 1 | 2020 | 181 | 0.160 |
Why?
| | Choledochal Cyst | 1 | 1998 | 20 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 3 | 2007 | 226 | 0.160 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 334 | 0.160 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 180 | 0.160 |
Why?
| | Organ Specificity | 2 | 2013 | 278 | 0.160 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1998 | 18 | 0.160 |
Why?
| | Interferon-alpha | 2 | 2011 | 191 | 0.160 |
Why?
| | Tissue Culture Techniques | 2 | 2021 | 67 | 0.160 |
Why?
| | Neurogenesis | 1 | 2019 | 105 | 0.160 |
Why?
| | Hybridomas | 2 | 1995 | 233 | 0.160 |
Why?
| | Skin | 1 | 2022 | 657 | 0.160 |
Why?
| | Glioblastoma | 1 | 2000 | 262 | 0.160 |
Why?
| | Neuromyelitis Optica | 1 | 2019 | 112 | 0.160 |
Why?
| | Brazil | 1 | 2017 | 109 | 0.150 |
Why?
| | Autoantibodies | 3 | 2021 | 1335 | 0.150 |
Why?
| | Cranial Nerve Diseases | 1 | 2017 | 42 | 0.150 |
Why?
| | Dexamethasone | 2 | 2017 | 320 | 0.150 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2019 | 185 | 0.150 |
Why?
| | Movement Disorders | 1 | 2017 | 45 | 0.150 |
Why?
| | Memory Disorders | 2 | 2016 | 168 | 0.150 |
Why?
| | Microfilament Proteins | 1 | 2017 | 134 | 0.150 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 140 | 0.140 |
Why?
| | Transcription Factors | 1 | 2005 | 1570 | 0.140 |
Why?
| | Muscular Diseases | 1 | 2017 | 107 | 0.140 |
Why?
| | Brain Ischemia | 1 | 2020 | 310 | 0.140 |
Why?
| | Ticks | 1 | 2016 | 12 | 0.140 |
Why?
| | Encephalitis Viruses, Tick-Borne | 1 | 2016 | 7 | 0.140 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 217 | 0.140 |
Why?
| | Protein Binding | 3 | 2016 | 1975 | 0.140 |
Why?
| | Encephalopathy, Bovine Spongiform | 1 | 1995 | 2 | 0.140 |
Why?
| | Culicidae | 1 | 2016 | 29 | 0.140 |
Why?
| | Presynaptic Terminals | 1 | 2016 | 58 | 0.140 |
Why?
| | Colorado | 5 | 2022 | 4196 | 0.140 |
Why?
| | Microcephaly | 1 | 2016 | 54 | 0.140 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 104 | 0.140 |
Why?
| | Interferon-gamma | 1 | 2019 | 736 | 0.140 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 1995 | 14 | 0.130 |
Why?
| | Biliary Atresia | 1 | 1998 | 224 | 0.130 |
Why?
| | Agricultural Workers' Diseases | 1 | 1995 | 32 | 0.130 |
Why?
| | DNA | 3 | 2017 | 1388 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2023 | 2275 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 551 | 0.130 |
Why?
| | Muscle Hypotonia | 1 | 2015 | 31 | 0.130 |
Why?
| | Spleen | 4 | 2011 | 510 | 0.130 |
Why?
| | Myocardium | 3 | 2005 | 970 | 0.130 |
Why?
| | Brain Stem | 1 | 1995 | 104 | 0.130 |
Why?
| | Cell Count | 2 | 2005 | 315 | 0.130 |
Why?
| | Chikungunya virus | 1 | 2016 | 63 | 0.130 |
Why?
| | Cricetinae | 3 | 2012 | 262 | 0.130 |
Why?
| | Medulla Oblongata | 1 | 1994 | 33 | 0.130 |
Why?
| | Nerve Fibers | 1 | 1995 | 89 | 0.130 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 827 | 0.130 |
Why?
| | Cerebral Infarction | 1 | 1994 | 45 | 0.130 |
Why?
| | Fingolimod Hydrochloride | 1 | 2015 | 32 | 0.130 |
Why?
| | Virus Cultivation | 1 | 2014 | 25 | 0.130 |
Why?
| | Demyelinating Diseases | 1 | 1995 | 79 | 0.130 |
Why?
| | West Nile Virus Vaccines | 1 | 2014 | 1 | 0.130 |
Why?
| | Endopeptidases | 1 | 1994 | 73 | 0.120 |
Why?
| | Receptors, Interleukin-17 | 1 | 2014 | 5 | 0.120 |
Why?
| | Aged | 9 | 2019 | 19657 | 0.120 |
Why?
| | Facial Nerve | 2 | 2007 | 33 | 0.120 |
Why?
| | Neuronal Plasticity | 1 | 2016 | 219 | 0.120 |
Why?
| | rac GTP-Binding Proteins | 2 | 2012 | 36 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 2005 | 46 | 0.120 |
Why?
| | Epilepsy | 1 | 1998 | 290 | 0.120 |
Why?
| | Fibroblasts | 4 | 2007 | 842 | 0.120 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2014 | 25 | 0.120 |
Why?
| | Microarray Analysis | 1 | 2014 | 124 | 0.120 |
Why?
| | Treponema pallidum | 1 | 2013 | 7 | 0.120 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2005 | 84 | 0.120 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 296 | 0.120 |
Why?
| | Bacterial Toxins | 2 | 2012 | 106 | 0.120 |
Why?
| | Practice Guidelines as Topic | 3 | 2007 | 1440 | 0.120 |
Why?
| | Kidney | 2 | 2011 | 1353 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 900 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 1996 | 371 | 0.120 |
Why?
| | Tachycardia | 1 | 2013 | 48 | 0.110 |
Why?
| | Propidium | 1 | 2013 | 4 | 0.110 |
Why?
| | Hydro-Lyases | 1 | 2013 | 4 | 0.110 |
Why?
| | Complement System Proteins | 1 | 2016 | 294 | 0.110 |
Why?
| | Immunotherapy, Adoptive | 2 | 1993 | 191 | 0.110 |
Why?
| | Cryoultramicrotomy | 1 | 2013 | 3 | 0.110 |
Why?
| | Biomarkers | 2 | 2017 | 3588 | 0.110 |
Why?
| | Buffers | 1 | 2013 | 56 | 0.110 |
Why?
| | Cerebrospinal Fluid Proteins | 2 | 2005 | 9 | 0.110 |
Why?
| | Myocytes, Cardiac | 2 | 2009 | 472 | 0.110 |
Why?
| | Leukocytosis | 2 | 2005 | 34 | 0.110 |
Why?
| | Rats | 7 | 2012 | 5392 | 0.110 |
Why?
| | History, 18th Century | 2 | 2010 | 23 | 0.110 |
Why?
| | Phagosomes | 1 | 2012 | 43 | 0.110 |
Why?
| | B-Lymphocytes | 2 | 2009 | 770 | 0.110 |
Why?
| | Drug Design | 1 | 2013 | 160 | 0.110 |
Why?
| | Glutamic Acid | 1 | 2014 | 224 | 0.110 |
Why?
| | Etoposide | 2 | 2003 | 149 | 0.110 |
Why?
| | Genetic Techniques | 2 | 2011 | 60 | 0.100 |
Why?
| | Cytoplasm | 1 | 2013 | 269 | 0.100 |
Why?
| | STAT5 Transcription Factor | 1 | 2012 | 43 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 410 | 0.100 |
Why?
| | Fever | 1 | 2013 | 283 | 0.100 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2011 | 8 | 0.100 |
Why?
| | Nitrendipine | 1 | 1991 | 13 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2005 | 1945 | 0.100 |
Why?
| | Cyclosporins | 1 | 1991 | 60 | 0.100 |
Why?
| | Verapamil | 1 | 1991 | 32 | 0.100 |
Why?
| | Cerebral Cortex | 2 | 2005 | 416 | 0.100 |
Why?
| | Histocytochemistry | 1 | 2011 | 82 | 0.100 |
Why?
| | T-Lymphocytes | 3 | 1998 | 1774 | 0.100 |
Why?
| | Fatal Outcome | 3 | 2009 | 287 | 0.100 |
Why?
| | Infant | 5 | 2022 | 8293 | 0.100 |
Why?
| | GTP-Binding Proteins | 1 | 2011 | 147 | 0.100 |
Why?
| | Caspases, Effector | 1 | 2010 | 2 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2003 | 770 | 0.090 |
Why?
| | Medical Illustration | 1 | 2010 | 9 | 0.090 |
Why?
| | History, 17th Century | 1 | 2010 | 18 | 0.090 |
Why?
| | Glutamate Plasma Membrane Transport Proteins | 1 | 2009 | 5 | 0.090 |
Why?
| | Hippocampus | 2 | 2005 | 735 | 0.090 |
Why?
| | Interferon Regulatory Factors | 1 | 2010 | 31 | 0.090 |
Why?
| | Virus Physiological Phenomena | 1 | 2009 | 6 | 0.090 |
Why?
| | Disease Vectors | 1 | 2009 | 10 | 0.090 |
Why?
| | Greenhouse Effect | 1 | 2009 | 8 | 0.090 |
Why?
| | Microscopy | 1 | 2011 | 125 | 0.090 |
Why?
| | Animals, Wild | 1 | 2009 | 47 | 0.090 |
Why?
| | United Kingdom | 2 | 2003 | 236 | 0.090 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2009 | 10 | 0.090 |
Why?
| | Muscle, Skeletal | 2 | 2017 | 1515 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2009 | 2657 | 0.090 |
Why?
| | Smad1 Protein | 1 | 2009 | 20 | 0.090 |
Why?
| | Smad3 Protein | 1 | 2009 | 47 | 0.090 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2009 | 12 | 0.090 |
Why?
| | Microtubule-Associated Proteins | 2 | 2012 | 188 | 0.090 |
Why?
| | Mutation | 4 | 2014 | 3457 | 0.080 |
Why?
| | Kinetics | 3 | 2005 | 1624 | 0.080 |
Why?
| | DNA Primers | 2 | 2003 | 533 | 0.080 |
Why?
| | Autophagy | 1 | 2012 | 315 | 0.080 |
Why?
| | Receptors, Virus | 2 | 2005 | 78 | 0.080 |
Why?
| | Virus Activation | 3 | 2003 | 80 | 0.080 |
Why?
| | Reperfusion Injury | 1 | 1991 | 276 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2013 | 597 | 0.080 |
Why?
| | Bacterial Proteins | 2 | 2012 | 759 | 0.080 |
Why?
| | Epidural Space | 1 | 2008 | 6 | 0.080 |
Why?
| | Myokymia | 1 | 2007 | 3 | 0.080 |
Why?
| | Schizophrenia, Paranoid | 1 | 2007 | 10 | 0.080 |
Why?
| | STAT2 Transcription Factor | 1 | 2007 | 3 | 0.080 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2008 | 87 | 0.080 |
Why?
| | Prognosis | 3 | 2019 | 3443 | 0.080 |
Why?
| | Developing Countries | 1 | 2009 | 255 | 0.080 |
Why?
| | Adolescent | 6 | 2020 | 18480 | 0.080 |
Why?
| | Seizures | 2 | 2008 | 345 | 0.080 |
Why?
| | Intervertebral Disc | 1 | 2008 | 37 | 0.080 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2007 | 50 | 0.080 |
Why?
| | Retrospective Studies | 6 | 2022 | 12978 | 0.080 |
Why?
| | Cell Movement | 2 | 2003 | 896 | 0.080 |
Why?
| | Morbidity | 1 | 2008 | 296 | 0.080 |
Why?
| | Disease Reservoirs | 1 | 2007 | 20 | 0.070 |
Why?
| | Herpesvirus Vaccines | 1 | 2007 | 4 | 0.070 |
Why?
| | Vero Cells | 3 | 2012 | 69 | 0.070 |
Why?
| | Herpesviridae | 1 | 2007 | 20 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1633 | 0.070 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 280 | 0.070 |
Why?
| | Lung Transplantation | 1 | 2009 | 263 | 0.070 |
Why?
| | Global Health | 1 | 2009 | 310 | 0.070 |
Why?
| | Survival Rate | 1 | 2011 | 1720 | 0.070 |
Why?
| | Hemagglutinins, Viral | 1 | 1986 | 6 | 0.070 |
Why?
| | Hepatovirus | 1 | 1986 | 3 | 0.070 |
Why?
| | Risk | 1 | 2009 | 853 | 0.070 |
Why?
| | Disease Transmission, Infectious | 1 | 2007 | 56 | 0.070 |
Why?
| | Meningitis, Aseptic | 2 | 2003 | 15 | 0.070 |
Why?
| | Mice, Inbred Strains | 4 | 1993 | 405 | 0.070 |
Why?
| | Transfusion Reaction | 1 | 2007 | 79 | 0.070 |
Why?
| | Virus Latency | 1 | 2007 | 84 | 0.070 |
Why?
| | S-Nitroso-N-Acetylpenicillamine | 1 | 2005 | 5 | 0.070 |
Why?
| | Serologic Tests | 1 | 2005 | 52 | 0.070 |
Why?
| | Cell Division | 2 | 2000 | 776 | 0.070 |
Why?
| | Glutathione | 1 | 2007 | 324 | 0.070 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2005 | 48 | 0.070 |
Why?
| | Risk Factors | 4 | 2009 | 9000 | 0.070 |
Why?
| | Mice, Inbred C57BL | 4 | 2013 | 4908 | 0.070 |
Why?
| | Interferon beta-1a | 1 | 2005 | 12 | 0.070 |
Why?
| | Osmolar Concentration | 1 | 2005 | 185 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 1158 | 0.070 |
Why?
| | Orthoreovirus, Avian | 1 | 2005 | 1 | 0.070 |
Why?
| | Analgesics | 1 | 2007 | 159 | 0.070 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2005 | 58 | 0.070 |
Why?
| | England | 2 | 2000 | 68 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2007 | 6561 | 0.060 |
Why?
| | Administration, Oral | 2 | 2004 | 756 | 0.060 |
Why?
| | Saimiri | 1 | 2004 | 6 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 1868 | 0.060 |
Why?
| | Neurophysiology | 1 | 1984 | 16 | 0.060 |
Why?
| | Nuclear Lamina | 1 | 2004 | 10 | 0.060 |
Why?
| | Nuclear Pore | 1 | 2004 | 14 | 0.060 |
Why?
| | Digestive System | 1 | 2004 | 30 | 0.060 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 965 | 0.060 |
Why?
| | Nuclear Localization Signals | 1 | 2004 | 14 | 0.060 |
Why?
| | Serotyping | 1 | 2004 | 32 | 0.060 |
Why?
| | Ultraviolet Rays | 2 | 1999 | 381 | 0.060 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2004 | 26 | 0.060 |
Why?
| | Pancreas Transplantation | 1 | 2004 | 68 | 0.060 |
Why?
| | Random Allocation | 1 | 2005 | 344 | 0.060 |
Why?
| | Thalamus | 1 | 2005 | 80 | 0.060 |
Why?
| | Pregnancy | 1 | 2016 | 5691 | 0.060 |
Why?
| | Down-Regulation | 1 | 2007 | 627 | 0.060 |
Why?
| | Retinal Ganglion Cells | 1 | 1985 | 92 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 969 | 0.060 |
Why?
| | Inclusion Bodies, Viral | 1 | 2003 | 2 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2021 | 502 | 0.060 |
Why?
| | AIDS-Related Opportunistic Infections | 2 | 2009 | 113 | 0.060 |
Why?
| | Vinculin | 1 | 2003 | 11 | 0.060 |
Why?
| | Glycoproteins | 1 | 2005 | 319 | 0.060 |
Why?
| | Enterovirus B, Human | 1 | 2023 | 24 | 0.060 |
Why?
| | Reflex, Stretch | 1 | 1983 | 9 | 0.060 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2003 | 36 | 0.060 |
Why?
| | Skin Diseases, Vesiculobullous | 1 | 2003 | 17 | 0.060 |
Why?
| | Hepatolenticular Degeneration | 1 | 1983 | 18 | 0.060 |
Why?
| | Herpesvirus 2, Human | 1 | 2003 | 28 | 0.060 |
Why?
| | Chorea | 1 | 1983 | 12 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2017 | 4596 | 0.060 |
Why?
| | Infusions, Intravenous | 1 | 2004 | 380 | 0.060 |
Why?
| | Isoxazoles | 1 | 2023 | 56 | 0.060 |
Why?
| | Adrenal Cortex Hormones | 1 | 2007 | 521 | 0.060 |
Why?
| | Liver | 1 | 2011 | 1816 | 0.060 |
Why?
| | District of Columbia | 1 | 2022 | 27 | 0.060 |
Why?
| | Luciferases | 1 | 2003 | 143 | 0.060 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1384 | 0.060 |
Why?
| | Muscular Dystrophies | 1 | 1983 | 36 | 0.060 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 41 | 0.060 |
Why?
| | Mice, Inbred BALB C | 2 | 1998 | 1206 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2023 | 139 | 0.050 |
Why?
| | Genes, Reporter | 1 | 2003 | 270 | 0.050 |
Why?
| | Retina | 1 | 1985 | 278 | 0.050 |
Why?
| | Ribavirin | 1 | 2003 | 88 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 334 | 0.050 |
Why?
| | AIDS Dementia Complex | 1 | 2002 | 52 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 367 | 0.050 |
Why?
| | Transfection | 1 | 2004 | 888 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1474 | 0.050 |
Why?
| | Models, Biological | 2 | 2003 | 1715 | 0.050 |
Why?
| | I-kappa B Proteins | 1 | 2002 | 80 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 618 | 0.050 |
Why?
| | Body Fluids | 1 | 2001 | 62 | 0.050 |
Why?
| | Electromyography | 2 | 2017 | 326 | 0.050 |
Why?
| | Endoplasmic Reticulum | 1 | 2003 | 241 | 0.050 |
Why?
| | Patients | 1 | 2002 | 175 | 0.050 |
Why?
| | Ligands | 1 | 2003 | 567 | 0.050 |
Why?
| | Radiography | 1 | 2004 | 861 | 0.050 |
Why?
| | Creatine Kinase | 1 | 2001 | 75 | 0.050 |
Why?
| | Fas-Associated Death Domain Protein | 1 | 2000 | 16 | 0.050 |
Why?
| | Pain | 1 | 2007 | 735 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2004 | 2071 | 0.050 |
Why?
| | Haplorhini | 1 | 2000 | 62 | 0.050 |
Why?
| | Phenotype | 1 | 2009 | 3003 | 0.050 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 34 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2017 | 3171 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2000 | 115 | 0.050 |
Why?
| | Species Specificity | 2 | 1995 | 565 | 0.050 |
Why?
| | Nitric Oxide | 1 | 2005 | 892 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 4 | 2009 | 2478 | 0.050 |
Why?
| | Bunyamwera virus | 1 | 2019 | 3 | 0.050 |
Why?
| | Administration, Intravenous | 1 | 2020 | 136 | 0.050 |
Why?
| | Knee Joint | 1 | 1983 | 353 | 0.050 |
Why?
| | Recurrence | 3 | 1995 | 975 | 0.040 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2020 | 48 | 0.040 |
Why?
| | Population Surveillance | 1 | 2003 | 413 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 2851 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2020 | 95 | 0.040 |
Why?
| | Gerstmann-Straussler-Scheinker Disease | 1 | 1999 | 1 | 0.040 |
Why?
| | Creosote | 1 | 1999 | 2 | 0.040 |
Why?
| | Antidiarrheals | 1 | 1999 | 15 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2005 | 1055 | 0.040 |
Why?
| | Muscle Weakness | 1 | 1999 | 82 | 0.040 |
Why?
| | Jejunum | 1 | 1999 | 30 | 0.040 |
Why?
| | Virus Attachment | 1 | 2018 | 11 | 0.040 |
Why?
| | Acrylates | 1 | 1999 | 47 | 0.040 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2004 | 540 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 48 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 559 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 4552 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2000 | 298 | 0.040 |
Why?
| | Age Factors | 1 | 2005 | 2995 | 0.040 |
Why?
| | Epitopes | 2 | 1991 | 443 | 0.040 |
Why?
| | Arboviruses | 1 | 2017 | 9 | 0.040 |
Why?
| | Antimicrobial Stewardship | 1 | 2020 | 95 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 2004 | 585 | 0.040 |
Why?
| | Vasculitis | 1 | 1998 | 75 | 0.040 |
Why?
| | Neural Pathways | 1 | 1999 | 277 | 0.040 |
Why?
| | In Vitro Techniques | 2 | 1999 | 1094 | 0.040 |
Why?
| | Neural Conduction | 1 | 2017 | 81 | 0.040 |
Why?
| | Plant Extracts | 1 | 1999 | 165 | 0.040 |
Why?
| | Brain Mapping | 1 | 2000 | 532 | 0.040 |
Why?
| | Atrophy | 1 | 2017 | 164 | 0.040 |
Why?
| | Colon | 1 | 1999 | 238 | 0.040 |
Why?
| | Liver Transplantation | 1 | 2004 | 847 | 0.040 |
Why?
| | CA3 Region, Hippocampal | 1 | 2016 | 6 | 0.040 |
Why?
| | Metagenomics | 1 | 2017 | 134 | 0.040 |
Why?
| | Spatial Memory | 1 | 2016 | 16 | 0.040 |
Why?
| | Complement Pathway, Classical | 1 | 2016 | 19 | 0.040 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 505 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2002 | 1167 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 356 | 0.030 |
Why?
| | Meat Products | 1 | 1995 | 25 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1995 | 67 | 0.030 |
Why?
| | Immunity, Cellular | 1 | 1998 | 270 | 0.030 |
Why?
| | Food Handling | 1 | 1995 | 48 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 938 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2000 | 1795 | 0.030 |
Why?
| | Phenylketonurias | 1 | 1995 | 13 | 0.030 |
Why?
| | Young Adult | 2 | 2022 | 10793 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2017 | 252 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 1995 | 413 | 0.030 |
Why?
| | Ammonium Chloride | 1 | 1994 | 4 | 0.030 |
Why?
| | Chymotrypsin | 1 | 1994 | 21 | 0.030 |
Why?
| | Necrosis | 2 | 1998 | 230 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2019 | 732 | 0.030 |
Why?
| | Cognition Disorders | 2 | 2009 | 529 | 0.030 |
Why?
| | Complement Activation | 1 | 2016 | 350 | 0.030 |
Why?
| | Antibody Affinity | 1 | 1993 | 55 | 0.030 |
Why?
| | Base Sequence | 2 | 1995 | 2159 | 0.030 |
Why?
| | DNA Damage | 1 | 1995 | 357 | 0.030 |
Why?
| | Cell Survival | 2 | 2005 | 1047 | 0.030 |
Why?
| | Co-Repressor Proteins | 1 | 2013 | 17 | 0.030 |
Why?
| | Thymidine Kinase | 2 | 1989 | 14 | 0.030 |
Why?
| | Neuropsychological Tests | 2 | 2008 | 1032 | 0.030 |
Why?
| | Syndrome | 2 | 2007 | 344 | 0.030 |
Why?
| | Cattle | 1 | 1995 | 978 | 0.030 |
Why?
| | Trigeminal Ganglion | 2 | 1989 | 22 | 0.030 |
Why?
| | Occupational Exposure | 1 | 1995 | 277 | 0.030 |
Why?
| | Anti-HIV Agents | 1 | 1999 | 664 | 0.030 |
Why?
| | bcl-X Protein | 1 | 2012 | 41 | 0.030 |
Why?
| | Hemagglutination | 1 | 1991 | 7 | 0.030 |
Why?
| | Triterpenes | 1 | 2012 | 17 | 0.030 |
Why?
| | Binding Sites, Antibody | 1 | 1991 | 38 | 0.030 |
Why?
| | Immunoglobulin Isotypes | 1 | 1991 | 32 | 0.030 |
Why?
| | Proteolysis | 1 | 2012 | 146 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2012 | 155 | 0.030 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 83 | 0.030 |
Why?
| | Cohort Studies | 1 | 2022 | 5116 | 0.030 |
Why?
| | CD8 Antigens | 1 | 1991 | 71 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 2013 | 174 | 0.030 |
Why?
| | Clone Cells | 1 | 1991 | 248 | 0.020 |
Why?
| | Diuresis | 1 | 1991 | 8 | 0.020 |
Why?
| | CD4 Antigens | 1 | 1991 | 126 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 394 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 1998 | 2874 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 1991 | 510 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 341 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2012 | 189 | 0.020 |
Why?
| | Antibody Formation | 1 | 1991 | 276 | 0.020 |
Why?
| | Calcium Channels | 1 | 1991 | 150 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2009 | 9 | 0.020 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2009 | 13 | 0.020 |
Why?
| | CD11 Antigens | 1 | 2009 | 32 | 0.020 |
Why?
| | Trigeminal Nerve | 1 | 1989 | 28 | 0.020 |
Why?
| | Esophagitis | 1 | 1989 | 66 | 0.020 |
Why?
| | Paresis | 1 | 2009 | 31 | 0.020 |
Why?
| | Prospective Studies | 2 | 1998 | 6471 | 0.020 |
Why?
| | Incidence | 1 | 1995 | 2424 | 0.020 |
Why?
| | Precipitin Tests | 1 | 1988 | 93 | 0.020 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 1988 | 37 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2009 | 154 | 0.020 |
Why?
| | Optic Neuritis | 1 | 2009 | 37 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 1988 | 165 | 0.020 |
Why?
| | Dendrites | 1 | 2009 | 88 | 0.020 |
Why?
| | Cross Reactions | 1 | 1988 | 116 | 0.020 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2009 | 79 | 0.020 |
Why?
| | Muscles | 1 | 1989 | 333 | 0.020 |
Why?
| | Mental Status Schedule | 1 | 2008 | 38 | 0.020 |
Why?
| | Isaacs Syndrome | 1 | 2007 | 5 | 0.020 |
Why?
| | Genetic Variation | 1 | 1993 | 926 | 0.020 |
Why?
| | Skin Diseases | 1 | 2009 | 125 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 126 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 1991 | 1067 | 0.020 |
Why?
| | Peripheral Nerves | 1 | 2007 | 65 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 1991 | 683 | 0.020 |
Why?
| | Gene Expression | 1 | 2012 | 1489 | 0.020 |
Why?
| | Oxidants | 1 | 2007 | 122 | 0.020 |
Why?
| | Genes, Regulator | 1 | 1986 | 33 | 0.020 |
Why?
| | Superoxides | 1 | 2007 | 221 | 0.020 |
Why?
| | Prednisone | 1 | 2007 | 235 | 0.020 |
Why?
| | Forelimb | 1 | 1986 | 29 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2012 | 811 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 1986 | 46 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 1998 | 4708 | 0.020 |
Why?
| | Synapses | 1 | 2009 | 344 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 1986 | 59 | 0.020 |
Why?
| | Hindlimb | 1 | 1986 | 137 | 0.020 |
Why?
| | Graft Rejection | 1 | 2009 | 555 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2005 | 38 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2005 | 96 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2016 | 5255 | 0.020 |
Why?
| | Politics | 1 | 1986 | 80 | 0.020 |
Why?
| | rho GTP-Binding Proteins | 1 | 2005 | 65 | 0.020 |
Why?
| | Integrins | 1 | 2005 | 82 | 0.020 |
Why?
| | Pathology | 1 | 1984 | 20 | 0.020 |
Why?
| | Vesicular stomatitis Indiana virus | 1 | 2004 | 13 | 0.020 |
Why?
| | Muromegalovirus | 1 | 2004 | 13 | 0.020 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2004 | 20 | 0.020 |
Why?
| | Massachusetts | 1 | 1984 | 141 | 0.020 |
Why?
| | Blood Pressure | 1 | 1991 | 1664 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2005 | 443 | 0.010 |
Why?
| | Aphasia | 1 | 2003 | 23 | 0.010 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2003 | 28 | 0.010 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 26 | 0.010 |
Why?
| | Immunotherapy | 1 | 2007 | 493 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 564 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2004 | 167 | 0.010 |
Why?
| | Schools, Medical | 1 | 1984 | 139 | 0.010 |
Why?
| | Patella | 1 | 1983 | 25 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 90 | 0.010 |
Why?
| | Lethal Dose 50 | 1 | 2002 | 12 | 0.010 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2003 | 90 | 0.010 |
Why?
| | Hydrolysis | 1 | 2003 | 176 | 0.010 |
Why?
| | Intestines | 1 | 1986 | 332 | 0.010 |
Why?
| | Fluorescence | 1 | 2003 | 159 | 0.010 |
Why?
| | Papillomaviridae | 1 | 2003 | 101 | 0.010 |
Why?
| | Epidermal Growth Factor | 1 | 2003 | 173 | 0.010 |
Why?
| | Hypertrophy | 1 | 1983 | 121 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 2002 | 116 | 0.010 |
Why?
| | Headache | 1 | 2003 | 128 | 0.010 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2002 | 52 | 0.010 |
Why?
| | DNA Fingerprinting | 1 | 2002 | 26 | 0.010 |
Why?
| | Electroencephalography | 1 | 2003 | 387 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 982 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2007 | 1178 | 0.010 |
Why?
| | Liver Diseases | 1 | 2003 | 282 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2002 | 546 | 0.010 |
Why?
| | Multienzyme Complexes | 1 | 2000 | 64 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 2000 | 61 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 874 | 0.010 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 407 | 0.010 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2000 | 139 | 0.010 |
Why?
| | Drug Resistance, Microbial | 2 | 1989 | 67 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2004 | 702 | 0.010 |
Why?
| | Ion Transport | 1 | 1999 | 60 | 0.010 |
Why?
| | Gene Deletion | 1 | 2000 | 361 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2004 | 984 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2003 | 516 | 0.010 |
Why?
| | HIV Seropositivity | 1 | 1998 | 111 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2002 | 610 | 0.010 |
Why?
| | Diet, Protein-Restricted | 1 | 1995 | 10 | 0.010 |
Why?
| | Phenylalanine | 1 | 1995 | 66 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2002 | 1346 | 0.010 |
Why?
| | Immunoblotting | 1 | 1994 | 307 | 0.010 |
Why?
| | Lymphocyte Depletion | 1 | 1993 | 119 | 0.010 |
Why?
| | Lymphocytes | 1 | 1994 | 347 | 0.010 |
Why?
| | Amino Acids | 1 | 1995 | 465 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2002 | 1965 | 0.010 |
Why?
| | Viral Plaque Assay | 1 | 1989 | 24 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1989 | 76 | 0.010 |
Why?
| | Chromosome Deletion | 1 | 1989 | 95 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1989 | 193 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2002 | 2220 | 0.010 |
Why?
| | Genes | 1 | 1989 | 231 | 0.010 |
Why?
| | Eye | 1 | 1989 | 106 | 0.000 |
Why?
| | Codon | 1 | 1986 | 89 | 0.000 |
Why?
|
|
Tyler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|